Abstract

Background: The metabolic syndrome (MS) has been shown to predict mortality due to cardiovascular disease. Currently, no population-based data on the prevalence of the MS is available in Peru. This study was aimed to assess the prevalence of the MS in urban Peruvian Mestizos, in the coastal districts of Lima, the capital of Peru.
Methods: A cross-sectional, epidemiological survey was undertaken, including 612 unrelated subjects aged 30–92 years (68.3% females). Prevalence of the MS was defined by the National Cholesterol Education Program Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (ATPIII) criteria. Insulin resistance was estimated by the homeostasis model assessment (HOMA).
Results: Age and sex standardized prevalence of the MS was 14.9% (13.2% in males, 16.5% in females). The MS was significantly more prevalent in females aged 45–59 years old (20.2% vs. 6.7%, p = 0.019). In individuals with the MS, the prevalence of insulin resistance (IR) was 45% in males/42% in females. Abdominal obesity (80% in males/92.8% in females), and low HDL cholesterol (55% males/75.4% females), but neither hypertriglyceridemia (85% in males/81.2% females) nor high fasting glucose (55% in males/36.2 % females) were more common in females. Prevalence of arterial hypertension was similar in both sexes.
Conclusions: In this Mestizo Peruvian population, prevalence of the MS is relatively low as compared to other ethnic groups; the higher prevalence in females is likely due to a higher prevalence of abdominal obesity. Overall, abdominal obesity and hypertriglyceridemia were the predominant combination of metabolic disorders in individuals fulfilling criteria for the diagnosis of the MS.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

cover image Metabolic Syndrome and Related Disorders
Metabolic Syndrome and Related Disorders
Volume 4Issue Number 1Spring 2006
Pages: 1 - 6
PubMed: 18370764

History

Published online: 20 March 2006
Published in print: Spring 2006

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Dr. Segundo Seclén
Diabetes Clinic, Cayetano Heredia National Hospital, Universidad Peruana Cayetano Heredia, Lima, Peru.
Arturo Villena
Diabetes Clinic, Cayetano Heredia National Hospital, Universidad Peruana Cayetano Heredia, Lima, Peru.
María Teresamartínez Larrad
San Carlos Clinical University Hospital, Madrid, Spain.
Dante Gamarra
Health Direction III–North Lima, Ministry of Health, Lima, Peru.
Bernabé Herrera
Health Direction III–North Lima, Ministry of Health, Lima, Peru.
Cristina Fernandez Pérez
San Carlos Clinical University Hospital, Madrid, Spain.
José Luis González Sánchez
San Carlos Clinical University Hospital, Madrid, Spain.
Manuel Serrano Ríos
San Carlos Clinical University Hospital, Madrid, Spain.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top